Technical Analysis for ALVO - Alvotech

Grade Last Price % Change Price Change
D 12.24 3.29% 0.39
ALVO closed up 3.29 percent on Friday, April 12, 2024, on 1.49 times normal volume.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Up

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
Wide Range Bar Range Expansion 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Narrow Range Bar Range Contraction 3.29%
Wide Bands Range Expansion 3.29%
Down 3 Days in a Row Weakness 3.29%
Down 4 Days in a Row Weakness 3.29%
Gapped Down Weakness 3.29%
Narrow Range Bar Range Contraction 3.03%

   Recent Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Alvotech Description

Alvotech is a biotech company, founded by Robert Wessman, focused solely on the development and manufacture of biosimilar medicines for patients worldwide. Alvotech seeks to be a global leader in the biosimilar space by delivering high quality, cost-effective products and services, enabled by a fully integrated approach and broad in-house capabilities. Alvotech’s current pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech has formed a network of strategic commercial partnerships to provide global reach and leverage local expertise in markets that include the U.S., Europe, Japan, China, and other Asian countries and large parts of South America, Africa and the Middle East. Alvotech’s commercial partners include Teva Pharmaceuticals, a US affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA; US), STADA Arzneimittel AG (EU and select other territories), Fuji Pharma Co., Ltd (TSE: 4554; Japan), Cipla/Cipla Gulf/Cipla Med Pro (NSE: CIPLA; Australia, New Zealand, South Africa/Africa), JAMP Pharma Corporation (Canada), Yangtze River Pharmaceutical (Group) Co., Ltd. (China), DKSH (SWX:DKSH; Taiwan, Hong Kong, Cambodia, Malaysia, Singapore, Indonesia, India, Bangladesh and Pakistan), YAS Holding LLC (Middle East and North Africa), Abdi Ibrahim (Turkey), Kamada Ltd. (NASDAQ and TASE: KMDA; Israel), Mega Labs, Stein, Libbs, Tuteur and Saval (Latin America) and Lotus Pharmaceuticals Co., Ltd. (1795:TT; Thailand, Vietnam, Philippines, and South Korea). Each commercial partnership covers a unique set of product(s) and territories. Except as specifically set forth therein, Alvotech disclaims responsibility for the content of periodic filings, disclosures and other reports made available by its partners.


Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Cancer Life Sciences Pharmaceutical Respiratory Diseases Autoimmune Disorders Osteoporosis Biosimilar Pharmaceutical Industry In India

Is ALVO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 18.0
52 Week Low 6.7
Average Volume 276,655
200-Day Moving Average 11.06
50-Day Moving Average 14.68
20-Day Moving Average 13.03
10-Day Moving Average 11.92
Average True Range 0.55
RSI (14) 36.71
ADX 37.03
+DI 13.18
-DI 37.50
Chandelier Exit (Long, 3 ATRs) 14.19
Chandelier Exit (Short, 3 ATRs) 12.65
Upper Bollinger Bands 15.90
Lower Bollinger Band 10.17
Percent B (%b) 0.36
BandWidth 44.00
MACD Line -0.85
MACD Signal Line -0.83
MACD Histogram -0.0128
Fundamentals Value
Market Cap 3.26 Billion
Num Shares 266 Million
EPS -2.81
Price-to-Earnings (P/E) Ratio -4.36
Price-to-Sales 65.35
Price-to-Book 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.91
Resistance 3 (R3) 13.74 13.02 13.63
Resistance 2 (R2) 13.02 12.60 13.10 13.53
Resistance 1 (R1) 12.63 12.33 12.83 12.80 13.44
Pivot Point 11.91 11.91 12.01 11.99 11.91
Support 1 (S1) 11.52 11.49 11.72 11.69 11.04
Support 2 (S2) 10.80 11.22 10.88 10.95
Support 3 (S3) 10.41 10.80 10.85
Support 4 (S4) 10.58